News
Given after surgery, AZ’s Tagrisso prevents lung cancer comi...
AstraZeneca opened its account at this year’ virtual ASCO meeting with data showing that adjuvant (post-surgery) use of Tagrisso delays the recurrence of EGFR-positive non-smal
